Neurosense Therapeutics Ltd.(NRSN)
$1.69-0.07 (-3.98%)
NRSN
Neurosense Therapeutics Ltd. financials statements
$1.69
At close:-0.07 (-3.98%)
Want to see NRSN full AI Analyst Report?
Neurosense Therapeutics Ltd. (NRSN) Income Statement
238 Followers
Neurosense Therapeutics Ltd. Income Statement
Last quarter (Q4 2025), Neurosense Therapeutics Ltd.'s total revenue was $0.00. In Q4, Neurosense Therapeutics Ltd.'s net income was $-3.21M. See Neurosense Therapeutics Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ -89.00K | $ 0.00 | |
| $ 11.09M | $ 9.90M | $ 12.05M | $ 13.46M | $ 5.59M | |
| Depreciation and Amortization | $ 16.00K | $ 22.00K | $ 21.00K | $ 89.00K | $ 3.00K |
| $ -11.11M | $ -9.88M | $ -9.64M | $ -12.23M | $ -2.88M | |
| $ -11.09M | $ -9.90M | $ -12.05M | $ -13.55M | $ -5.59M | |
| $ -40.00K | $ -308.00K | $ 1.94M | $ 1.21M | $ 1.55M | |
| $ -11.13M | $ -10.21M | $ -10.11M | $ -12.34M | $ -4.04M | |
| $ -11.13M | $ -10.21M | $ -10.11M | $ -12.34M | $ -4.04M | |
| Per Share Metrics | |||||
| Basic EPS | $ -8.80 | $ -11.00 | $ -16.60 | $ -21.40 | $ -4.60 |
| Diluted EPS | $ -8.80 | $ -11.00 | $ -16.60 | $ -21.40 | $ -4.60 |
| Weighted Average Shares Outstanding | 1.27M | 930.10K | 682.00K | 575.25K | 542.80K |
| Weighted Average Shares Outstanding (Diluted) | 1.27M | 930.10K | 682.00K | 575.25K | 542.80K |
Currency in USD
